Manasa will be starting a new role as a cancer bioengineering scientist at SageMedic in Redwood City, CA. She will be working with a group of oncologists and engineers to develop a genome-free high throughput ex-vivo test that will predict an individual’s optimal therapy from 3D microtumors created from the patient’s biopsy.

Good luck Manasa!